6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
23m ago	NOV Reports First Quarter 2026 Earnings
23m ago	Irenic Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering
24m ago	Turning Point Brands to Host Q1 2026 Conference Call
24m ago	Performance Shipping Inc. Announces Filing of 2025 Annual Report on Form 20-F
24m ago	Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment

About

Promis Neurosciences Inc. (NASDAQ:PMN) — investor relations, events, news, and company updates on 6ix.

Latest News

ProMIS Neurosciences Invited to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference

ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights

ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)

ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing

Financials

Revenue

$7.56 K

Market Cap

$112.19 M

EPS

-22.61

Community Chat

Ask AI